Laxmi Organic Industries Limited provides acetyl and specialty intermediate products in India and internationally. The company's acetyl intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol, acetic anhydride, and other proprietary solvents; and specialty intermediates comprise ketene and diketene derivatives, esters, amides, arylides, and fluorospeciality Intermediates. Its products are used in pharmaceuticals, agrochemicals, flexible packaging, auto coatings, printing inks, personal care, cosmetics, and other industrial applications. Laxmi Organic Industries Limited was incorporated in 1989 and is based in Mumbai, India. Laxmi Organic Industries Limited is a subsidiary of Yellow Stone Trust.
Revenue projections:
Revenue projections for LXCHEM Investors are expected to be cautious with LXCHEM, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.
Financial Ratios:
currentRatio
0.000000
forwardPE
31.744059
debtToEquity
13.506000
earningsGrowth
-0.382000
revenueGrowth
-0.035000
grossMargins
0.249360
operatingMargins
0.019630
trailingEps
3.590000
forwardEps
10.750000
LXCHEM's low Debt-to-Equity ratio indicates the company is not over-leveraged. By limiting its dependence on debt, LXCHEM reduces its financial risk and demonstrates a strong capital structure, making it a more stable investment option for those wary of excessive borrowing. Laxmi Organic Industries Limited's low earnings and revenue growth highlight a potential decline in profitability. This suggests that the company's financial health may be weakening, and profits could shrink as a result. LXCHEM's negative gross and operating margins signal that the company is not profitable, struggling to cover costs associated with production and operations. This could be a red flag for its financial performance moving forward. LXCHEM's forward EPS is higher than its trailing EPS, suggesting the company is expected to see an increase in profitability this year. This points to positive growth, indicating that LXCHEM is projected to improve its financial performance compared to the previous year.
Price projections:
Price projections for LXCHEM Price projections for LXCHEM have been revised downward over time, signaling decreasing optimism about the company's outlook. Analysts appear to be adjusting their expectations as concerns about future performance grow.
Recommendation changes over time:
Recommendations trend for LXCHEM
Analysts have signaled a sell bias for LXCHEM, but investors should consider a broad range of market indicators before making any decisions. This ensures a well-rounded understanding of LXCHEM's position in the market and helps avoid reactionary moves based solely on this sentiment.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
An in-depth look at the UK’s Q2 2025 GDP release by ONS,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.